The Cologuard assay demonstrates 92% sensitivity for detecting colorectal cancer, both outperforming traditional screening methods through DNA methylation detection. (J Cancer Res Ther)
CRC Research Finding
The CRC Digest
The CRC Digest
The Cologuard assay demonstrates 92% sensitivity for detecting colorectal cancer, both outperforming traditional screening methods through DNA methylation detection. (J Cancer Res Ther)